Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

O Launay; C Sadorge; N Jolly; B Poirier; S Bechet; D van der Vliet; V Seffer; N Fenner; K Dowling; R Giemza; J Johnson; A Ndiaye; M Vray; P Sansonetti; P Morand; C Poyart; D Lewis; M-L Gougeon

doi:10.1016/j.vaccine.2008.12.021

Back

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

Journal article

Peer reviewed

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

O Launay, C Sadorge, N Jolly, B Poirier, S Bechet, D van der Vliet, V Seffer, N Fenner, K Dowling, R Giemza, …

VACCINE, Vol.27(8), pp.1184-1191

18/02/2009

DOI: https://doi.org/10.1016/j.vaccine.2008.12.021

Abstract

Science & Technology

Life Sciences & Biomedicine

Immunology

Medicine

Research & Experimental

Research & Experimental Medicine

IMMUNOLOGY

MEDICINE

RESEARCH & EXPERIMENTAL

Shigella dysenteriae

Live attenuated vaccine

Vaccine shedding

IgA immune response

SERUM ANTIBODIES

FLEXNERI 2A

NATURAL IMMUNITY

SECRETING CELLS

LIPOPOLYSACCHARIDE

SONNEI

IMMUNIZATION

INFECTION

CHILDREN

INVASION

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000263712200006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

33 Record Views

31 Times Cited - Web of Science

See more details

Details

Title: Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial
Creators: O Launay
C Sadorge
N Jolly
B Poirier
S Bechet
D van der Vliet
V Seffer
N Fenner
K Dowling
R Giemza
J Johnson
A Ndiaye
M Vray
P Sansonetti
P Morand
C Poyart
D Lewis
M-L Gougeon
Publication Details: VACCINE, Vol.27(8), pp.1184-1191
Publisher: ELSEVIER SCI LTD
Date published: 18/02/2009
Date submitted: 17/05/2017
Identifiers: 99513139702346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

Abstract

Files and links (1)

Metrics

Details

Usage Policy